(4-BROMOTHIAZOL-2-YL)METHANAMINE HCL, 95.0%, 500mg

(1R,3S)-3-(Carbobenzoxyamino)cyclohexanecarboxylic Acid>98.0%(HPLC)(T)100mg

(R)-Methyl 2-(pyrrolidin-2-yl)acetate hydrochloride, 95.0%, 1g

tert-Butyl 2-(triphenylphosphoranylidene)acetate, 95.00%, 25g

(2r)-3,3-Difluoro-2-methyl-azetidine;hydrochloride, 98%, 5g

METHYL 4,5-DIBROMO-2-FLUOROBENZOATE, 95.0%, 250mg

N-Boc-3-Carboethoxy-4-piperidone, 95.0%, 1g

(S)-2-bromobutanoic acid, 98%, 100mg

(3R,4R)-1-(tert-Butoxycarbonyl)-4-methylpyrrolidine-3-carboxylic acid, 95.0%, 250mg

Methyl 5-cyclopropyl-1H-pyrazole-4-carboxylate, 95.0%, 1g

GC capillary column ROTI®Cap-1, 30 m, 0.32 mm, 1.00 µm, 1 Piece(s)

Polyethylene Glycol 20025g

(S)-1-(6-FLUOROPYRIDIN-2-YL)ETHANAMINE HCL, 95.0%, 250mg